• 21/10/2020

    KNCV implementing partner for new LIFT-TB initiative

    KNCV Tuberculosis Foundation is one of the implementing partners of the LIFT-TB initiative of TB Alliance,…

    Lees meer

  • 19/10/2020

    Riziki: “I encourage any TB patient to use 99DOTS if they can”

    The KNCV-led and Stop TB Partnership funded TB REACH project in Tanzania introduced 99DOTS (medication sleeves) as a Digital…

    Lees meer

  • 02/10/2020

    WoW trucks: revolutionary TB and COVID-19 testing in Nigeria

    KNCV Tuberculosis Foundation (KNCV) Nigeria contributes in a revolutionary way to the fight against tuberculosis (TB) and COVID-19. Recently the…

    Lees meer

  • 02/10/2020

    Behind the mask: working on the WoW-truck

    Chimezie Dimkpa, the KNCV Nigeria ACF (Active Case Finding) radiographer onboard the WoW truck shares his experience working with patients…

    Lees meer

  • 28/08/2020

    TREATS will begin testing for COVID-19 in Zambia using TB testing facilities

    The TREATS study will soon begin testing for COVID-19 in the Bwacha – Ngungu community of Kabwe in Zambia,…

    Lees meer

  • 25/08/2020

    Mustapha Gidado new Executive Director of KNCV Tuberculosis Foundation

    Dr. Mustapha Gidado takes up the position of Executive Director of KNCV Tuberculosis Foundation. He succeeds Kitty van Weezenbeek, who…

    Lees meer

  • 25/08/2020

    Interview Executive Director Mustapha Gidado

    He speaks passionate, articulated, and with emphasis on every word. Meet with Dr. Mustapha Gidado and you will get his…

    Lees meer

  • 24/08/2020

    KNCV provides hearing aids for Ethiopian TB patients

    It’s been a known fact for years that the treatment for multidrug-resistant tuberculosis, is associated with severe and often permanent…

    Lees meer

  • 14/08/2020

    Successful KNCV-led TB REACH-projects test Digital Adherence Technologies in the fight against TB

    Since 2018, KNCV has rolled-out Digital Adherence Technology (DAT) demonstration projects in the Philippines and Tanzania. These TB REACH projects…

    Lees meer

  • 14/08/2020

    The story of Angelito: “99DOTS helped me get cured of TB”

    My name is Angelito* and I am a TB survivor from Mandaluyong City, Philippines. Angelito in…

    Lees meer

  • 03/08/2020

    European approval for new drug against highly resistant TB

    The European Commission has given conditional market authorisation for the three-drug, six-month, all-oral regimen for the treatment of highly resistant…

    Lees meer

  • 30/07/2020

    Mustapha Gidado new Executive Director of KNCV

    Dr. Mustapha Gidado is taking office as the new Executive Director of KNCV Tuberculosis Foundation. He succeeds Kitty van Weezenbeek,…

    Lees meer

  • 22/07/2020

    Summary to the KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers

    On Thursday 16th of July 2020 KNCV held its next webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19:…

    Lees meer

  • 16/07/2020

    KNCV takes over TIME implementation

    KNCV Tuberculosis Foundation is taking over implementation of the TIME modelling framework from the London School of Hygiene and Tropical…

    Lees meer

  • 13/07/2020

    Summary & video of the KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs – Part 2

    On 2 July 2020 KNCV held its third webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19: Lessons from…

    Lees meer
Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Ghana
Indonesia
Kazachstan
Kenya
Kyrgyzstan
Malawi
Namibia
Nigeria
Rwanda
South Africa
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Technical Assistance Strategy

New drugs & treatment regimens
Digital health solutions
Diagnosis & treatment of LTBI
TB Stigma reduction
Epidemiological measurement methodologies
New diagnostics and lab network design
People-Centered Framework for National Strategic Planning and HSS
Blended learning platform & methodologies

ASCENT
ASTTIE
Development of a comprehensive Digital Training Package
E-detect
GeneXpert MTB/RIF Test
IMPAACT4TB
PAVIA
People-Centered Framework for TB Programming
PODTEC
TB Alliance BPAL Project
The Global Fund to Fight AIDS, Tuberculosis and Malaria
TREATS

Our success stories

Challenge TB
Improved TB/HIV Prevention & Care – Building Models for the Future Project
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

Annual Report Summary 2019
KNCV 2-pager ASCENT
KNCV 2-pager Childhood TB
KNCV 2-pager Digital Health
KNCV 2-pager General
KNCV 2pager Right Diagnosis, Right Treatment
KNCV 2-pager TB Photovoices
KNCV 2-pager TB Stigma

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.